A clinical evaluation of implants in irradiated oral cancer patients

J Dent Res. 2002 Dec;81(12):856-9. doi: 10.1177/154405910208101212.

Abstract

In this prospective study, we determined the effects of the time interval between irradiation and implant therapy, implant location, bone-resection surgery, and irradiation dose on implant survival. We analyzed the survival of 446 implants inserted after radiotherapy over a period of up to 14 years in 130 consecutive patients treated for oral cancer. The 10-year overall Kaplan-Meier implant survival percentage is 78%. The difference in survival percentages of implants inserted < 1 year and >/= 1 year after irradiation (76% and 81%, respectively) is not significant. We concluded that implant survival is significantly influenced by the location (maxilla or mandible, 59% and 85%, respectively; p = 0.001), by the incidence of bone-resection surgery in the jaw where the implant was installed (p = 0.04), and by the irradiation dose at the implant site (< 50 Gray or >/= 50 Gray, p = 0.05).

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Cranial Irradiation / adverse effects*
  • Dental Implantation, Endosseous*
  • Dental Implants*
  • Dental Restoration Failure*
  • Female
  • Humans
  • Male
  • Mandible / surgery
  • Maxilla / surgery
  • Middle Aged
  • Mouth Neoplasms / radiotherapy
  • Proportional Hazards Models
  • Prospective Studies
  • Radiotherapy Dosage
  • Survival Analysis
  • Time Factors

Substances

  • Dental Implants